close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Quantum Biopharma Ltd. - Class B Subordinate Voting Shares (NQ:QNTM)

1.940 UNCHANGED
Delayed Quote Updated: 4:00 PM EST, Nov 11, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Quantum Biopharma Ltd. - Class B Subordinate Voting Shares

< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
News headline image
Quantum Biopharma Wins Reconsideration Motion by Dr. Raza Bokhari at the Court of Appeal for Ontario
Awards in favour of Quantum BioPharma Totalling $180,000 upheld and is now due 
From Quantum BioPharma
Via GlobeNewswire
News headline image
InvestorNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) Expands Reach of unbuzzd Through AATAC Retail Deal
Via Investor Brand Network
News headline image
Quantum BioPharma Licensee Celly Nutrition Announces Landmark Partnership with the Asian American Trade Associations Council (AATAC) to Expand Retail Availability of its Alcohol Detox Beverage unbuzzd™
From Quantum BioPharma
Via GlobeNewswire
News headline image
InvestorNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) Launches Alcohol-Metabolism Beverage in Puerto Rico
Via Investor Brand Network
News headline image
Quantum BioPharma Licensee Celly Nutrition Launches unbuzzd in Puerto Rico
From Quantum BioPharma
Via GlobeNewswire
News headline image
InvestorNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) Partners with Mass General on PET Imaging Study for Multiple Sclerosis
Via Investor Brand Network
News headline image
Quantum BioPharma Announces Joint Clinical Study With Massachusetts General Hospital Scientists to Validate a Novel Positron Emission Tomography (PET) Imaging Technique to Monitor Demyelination In Multiple Sclerosis
From Quantum BioPharma
Via GlobeNewswire
News headline image
InvestorNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) Closes $5 Million Offering to Advance Drug Development
Via Investor Brand Network
News headline image
Quantum Biopharma Announces Closing of Final $2.42 Million Tranche of $5 Million Total Financing on Improved Terms
From Quantum BioPharma
Via GlobeNewswire
News headline image
BioMedNewsBreaks — Quantum BioPharma Ltd. (NASDAQ: QNTM) Reports Q4 and Full-Year 2024 Financial Results, Highlights Breakthroughs in Alcohol Detox and MS Treatments
Via Investor Brand Network
News headline image
Quantum Biopharma's 2024 Financial Statements Show Strong Improvements in Cash, Working Capital, Operating Efficiency and the Removal of Material Uncertainty Related to Going Concern
Via ACCESS Newswire
News headline image
Quantum Biopharma’s 2024 Financial Statements Show Strong Improvements in Cash, Working Capital, Operating Efficiency and the Removal of Material Uncertainty Related to Going Concern
Completion of unbuzzd™ Clinical Trial and Multiple Sclerosis Drug Lucid-21-302 Phase 1 Trial Advance Company’s Pipeline of Products and Assets 
From Quantum BioPharma
Via GlobeNewswire
News headline image
InvestorNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) Appoints Terry Lynch to Board, Grants Options
Via Investor Brand Network
News headline image
Quantum Biopharma Announces Leading Crusader Against Naked Short Selling and Stock Manipulation, Terry Lynch Elected to Board of Directors
From Quantum BioPharma
Via GlobeNewswire
News headline image
Quantum BioPharma Stock Soars After Licensee Celly Nutrition Releases New Format Of Alcohol Detox Product – Retail Shrugs It Off ↗
Celly Nutrition has to pay 7% royalty on sales of alcohol detox product unbuzzd to Quantum until payments total $250 million and 3% royalty afterwards. 
Via Stocktwits
News headline image
InvestorNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) Launches Retail-Ready unbuzzd Stick Packs Across U.S. Stores
Via Investor Brand Network
News headline image
Quantum BioPharma Licensee Celly Nutrition Expands unbuzzd™ Alcohol Detox Product Lineup for Retail Sales
From Quantum BioPharma
Via GlobeNewswire
News headline image
Quantum BioPharma Continues to Grow Its Crypto Assets and Diversify Its Treasury With the Purchase of Another USD $1,500,000 Worth of Bitcoin (BTC) and Other Cryptocurrencies
From Quantum BioPharma
Via GlobeNewswire
News headline image
Let's have a look at the top gainers and losers in the middle of the day of today's session. ↗
Intrigued by the market activity in the middle of the day on Monday? Uncover the key winners and losers of today's session in our insightful analysis. 
Via Chartmill
News headline image
What's going on in today's after hours session ↗
As the regular session of the US market on Friday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment. 
Via Chartmill
News headline image
InvestorNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) Completes Phase 1 Trial for MS Treatment, Reports Positive Safety Results
Via Investor Brand Network
News headline image
Quantum Biopharma Announces Completion of the Phase 1 Multiple Ascending Dose Clinical Trial for its Experimental Multiple Sclerosis Drug Lucid-21-302
From Quantum BioPharma
Via GlobeNewswire
News headline image
Quantum BioPharma Continues to Diversify its Treasury with the Purchase of Another USD $1,000,000 Worth of Bitcoin (BTC) and Other Cryptocurrencies
From Quantum BioPharma
Via GlobeNewswire
News headline image
BioMedNewsBreaks — Quantum BioPharma Ltd. (NASDAQ: QNTM) Engages MZ Group for Investor Relations Strategy
Via Investor Brand Network
News headline image
Quantum Biopharma Engages MZ Group to Lead Strategic Investor Relations and Shareholder Communications Program
From Quantum BioPharma
Via GlobeNewswire
News headline image
BioMedNewsBreaks — Quantum BioPharma Ltd. (NASDAQ: QNTM) Engages Enterprise Canada, Empire Market Ventures for PR, Investor Awareness
Via Investor Brand Network
News headline image
Quantum Biopharma Engages Enterprise Canada and Empire Market Ventures to Lead Public Communications and Investor Awareness Programs
From Quantum BioPharma
Via GlobeNewswire
News headline image
Quantum BioPharma Heads For Best Week Ever — But Most Retail Traders Lament Missing Out On The Surge ↗
The company has attracted heavy attention after its dietary supplement, Unbuzzd, showed that it can reduce blood alcohol concentration rapidly in a clinical trial. 
Via Stocktwits
News headline image
Which stocks are moving on Thursday? ↗
Let's have a look at what is happening on the US markets one hour before the close of the markets on Thursday. Below you can find the top gainers and losers in today's session. 
Via Chartmill
News headline image
Quantum BioPharma Shares Are Up Over 80%: What's Going On? ↗
Quantum BioPharma shares are surging Thursday after its licensee, Celly Nutrition, engaged a New York investment bank to raise up to $10 million and explore a potential U.S. initial public offering. 
Via Benzinga
< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at /week.